Table 8.
Adverse Events After First DEB-TACE Therapy
| Items | VL Patients (n=49) | Non-VL Patients (n=237) | P value |
|---|---|---|---|
| Fever, No. (%) | 21 (42.9) | 127 (53.6) | 0.171 |
| Grade 1 | 16 (32.7) | 92 (38.8) | |
| Grade 2 | 5 (10.2) | 33 (13.9) | |
| Grade 3 | 0 (0.0) | 2 (0.8) | |
| Pain, No. (%) | 26 (53.1) | 102 (43.0) | 0.199 |
| Grade 1 | 7 (14.3) | 30 (12.7) | |
| Grade 2 | 15 (30.6) | 58 (24.5) | |
| Grade 3 | 4 (8.2) | 14 (5.9) | |
| Ascites (4 weeks after DEB-TACE), No. (%) | 14 (28.6) | 61 (25.7) | 0.681 |
| Grade 1 | 10 (20.4) | 47 (19.8) | |
| Grade 2 | 3 (6.1) | 9 (3.8) | |
| Grade 3 | 1 (2.0) | 5 (2.1) | |
| Nausea and vomiting, No. (%) | 8 (16.3) | 63 (26.6) | 0.130 |
| Garde 1 | 8 (16.3) | 63 (26.6) | |
| Grade 2 | 0 (0.0) | 0 (0.0) | |
| Grade 3 | 0 (0.0) | 0 (0.0) | |
| Gastrointestinal bleeding, No. (%) | 0 (0.0) | 1 (0.4) | 1.000 |
| Grade 1 | 0 (0.0) | 1 (0.4) | |
| Grade 2 | 0 (0.0) | 0 (0.0) | |
| Grade 3 | 0 (0.0) | 0 (0.0) |
Note: Comparison was determined by Fisher’s exact test or Chi-square test.
Abbreviations: VL, vascular lake; DEB-TACE, drug-eluting beads transarterial chemoembolization.